Company Profile

Epic Therapeutics Inc (AKA: Middlesex Sciences Inc)
Profile last edited on: 1/29/2019      CAGE:       UEI:

Business Identifier: Protein-matrix drug delivery
Year Founded
1993
First Award
1996
Latest Award
1996
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

220 Norwood Park South
Norwood, MA 02062
   (781) 440-0010
   N/A
   www.epictherapeutics.com
Location: Single
Congr. District: 08
County: Norfolk

Public Profile

Epic Therapeutics, Inc. has developed a proprietary, protein-matrix drug delivery technology, ProMaxx®, that is produced entirely in water and is substantially more versatile and cost-effective at solving today's pharmaceutical and biotech drug delivery problems than current technologies. In November 2002 Baxter Healthcare Corporation signed a definitive agreement to acquire Epic Therapeutics, Inc.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
1996 1 NIH $100,000
Project Title: Targeted Delivery of Microparticlized DNA for Vaccines
1996 1 NIH $99,998
Project Title: New Method For Making Pneumococcal Vaccines For Infants

Key People / Management

  Anthony Garramone -- President

  Jie Di

  Robert W Finberg

Company News

There are no news available.